Multifaceted Carbonized Metal–Organic Frameworks Synergize with Immune Checkpoint Inhibitors for Precision and Augmented Cuproptosis Cancer Therapy
Beijing Institute of Technology · National University of Singapore · +3 more institutions
Abstract
The discovery of cuproptosis, a copper-dependent mechanism of programmed cell death, has provided a way for cancer treatment. However, cuproptosis has inherent limitations, including potential cellular harm, the lack of targeting, and insufficient efficacy as a standalone treatment. Therefore, exogenously controlled combination treatments have emerged as key strategies for cuproptosis-based oncotherapy. In this study, a Cu2–xSe@cMOF nanoplatform was constructed for combined sonodynamic/cuproptosis/gas therapy. This platform enabled precise cancer cotreatment, with external control allowing the selective induction of cuproptosis in cancer cells. This approach effectively prevented cancer metastasis and…
Citation impact
- FWCI
- 20.37
- Percentile
- 100%
- References
- 54
Authors
4- CZChen Zhao
Beijing Institute of Technology, National University of Singapore
- XTXiaoying Tang
Beijing Institute of Technology
- XCXiaoyuan ChenCorresponding
Agency for Science, Technology and Research, National University of Singapore, Université Bourgogne Franche-Comté, Institute of Molecular and Cell Biology
- ZJZhenqi JiangCorresponding
Beijing Institute of Technology
Topics & keywords
- Cancer
- Cancer therapy
- Metal-organic framework
- Immune checkpoint
- Materials science
- Cancer research
- Nanotechnology
- Carbonization
Funding
- NUNational University of SingaporeAwards: NUHSRO/2021/034/TRP/09/Nanomedicine, NUHSRO/2023/008/NUSMed/TCE/LOA, NUHSRO/2020/133/Startup/08
- NRNational Research Foundation SingaporeAward: NRF- 000352-00
- MOMinistry of Education - SingaporeAward: MOE-000387-00
- NNNational Natural Science Foundation of ChinaAward: 32101153
- BIBeijing Institute of Technology
- BABeijing Association for Science and TechnologyAward: BYESS2023244
- NMNational Medical Research CouncilAwards: MOH-001388-00, MOH-001041, CG21APR1005